Prothena Corporation PLC
NASDAQ:PRTA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Prothena Corporation PLC
NASDAQ:PRTA
|
IE |
|
Neuropace Inc
NASDAQ:NPCE
|
US |
|
Equinor ASA
F:DNQ
|
NO |
|
MTM Critical Metals Ltd
OTC:MTMCF
|
AU |
|
Ferro-Alloy Resources Ltd
LSE:FAR
|
GG |
|
Sunshine Biopharma Inc
NASDAQ:SBFM
|
CA |
|
Alan Allman Associates SA
PAR:AAA
|
FR |
Intrinsic Value
The
intrinsic value for
Prothena Corporation PLC (PRTA)
under the Base Case is
hidden
USD.
Compared with the current market price of 10.65 USD, the stock appears
hidden
.
PRTA looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether PRTA usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Prothena Corporation PLC.
Fundamental Analysis
Revenue & Expenses Breakdown
Prothena Corporation PLC
Earnings Waterfall
Prothena Corporation PLC
The
intrinsic value for
Prothena Corporation PLC (PRTA)
under the Base Case is
hidden
USD.
Compared with the current market price of 10.65 USD, the stock appears hidden .